斯里兰卡国家癫痫中心药物难治性癫痫的手术结局
斯里兰卡国家癫痫中心2017年10月至2023年2月对19例非儿科药物难治性癫痫患者行癫痫手术,6个月随访时Engel I/II级占83.3%(10/12),1年75.0%(6/8),2年71.4%(5/7),QOLIE-31评分改善≥11.8分(P<0.001),5例(26.3%)发生轻微手术部位感染,2例(11.1%)持续视野象限盲。
要点
- 6个月Engel I/II级83.3%(10/12),1年75.0%(6/8),2年71.4%(5/7)。
- QOLIE-31评分改善≥11.8分(P<0.001),与癫痫结局或手术类型无关。
- 5例(26.3%)轻微手术部位感染,2例(11.1%)持续视野象限盲。
核心结论
- 作者认为癫痫手术在发展中国家有效,本组患者癫痫结局与全球相当,观察到有临床意义的QOL改善,这是斯里兰卡首份非儿科患者癫痫手术结局的已发表数据。
研究设计与样本
- 斯里兰卡国家癫痫中心(NEC)成立于2017年,描述了2017年10月至2023年2月接受癫痫手术的非儿科患者的癫痫结局、生活质量(QOL)影响和手术并发症。
- 19例年龄≥14岁患者在NEC接受癫痫手术,采用Engel分类评估癫痫结局,采用癫痫生活质量31(QOLIE-31)问卷评估QOL,手术并发症分为神经系统并发症和手术相关并发症。
主要发现
- 9例女性和10例男性患者接受手术,平均年龄27.5岁(范围14-44岁),平均随访时间10.5个月(范围6-55个月)。
- 12例患者接受颞叶切除术,6个月随访时83.3%(10/12)获得Engel I/II级良好癫痫结局,1年随访时6/8例(75.0%)和2年随访时5/7例(71.4%)获得良好结局。
- 7例患者接受颞叶外手术,1例失访;6个月随访时6/6例、1年随访时3/3例和2年随访时2/2例观察到无癫痫发作。
- 5例患者(26.3%)经历轻微术后手术部位感染,2例(11.1%)有持续视野象限盲。
- 无论癫痫结局或手术类型如何,均观察到QOL有意义改善(QOLIE-31评分变化≥11.8)(P < 0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The National Epilepsy Center (NEC) in Sri Lanka was established in 2017. Seizure outcome, effects on quality of life (QOL) and surgical complications among nonpediatric patients who underwent epilepsy surgery from October 2017 to February 2023 are described. METHODS: Nineteen patients (≥14 years) underwent epilepsy surgery at the NEC. We used Engel classification and Quality of Life in Epilepsy 31 (QOLIE-31) questionnaire to assess seizure outcome and QOL respectively. Surgical complications were categorized into neurological and complications related to surgery. RESULTS: Nine female and 10 male patients underwent surgery (mean age 27.5 years (range 14-44 years). The mean follow-up duration was 10.5 months (range 6-55 months). Twelve patients underwent temporal lobe resections. At 6-months follow-up, 83.3% (10/12) had favorable seizure outcomes with Engel class I/II. At 1-year follow-up 6/8 patients (75.0%) and at 2-year follow-up, 5/7 patients (71.4%) had a favorable outcome. Seven patients had extra-temporal lobe surgeries and one defaulted. Seizure freedom was observed in 6/6 at 6 months, 3/3 at 1-year, and 2/2 at 2-year follow-up. Five patients (26.3%) experienced minor post-operative surgical site infection. Two (11.1%) had persistent quadrantanopia. Meaningful improvement in QOL (change in QOLIE-31 score ≥11.8) was observed irrespective of seizure outcome or type of surgery (P < 0.001). CONCLUSIONS: Epilepsy surgery is effective in developing countries. Seizure outcomes in our patients are comparable to those worldwide. Clinically important QOL improvement was observed in our series. This is the first published data on epilepsy surgery outcomes in nonpediatric patients from Sri Lanka.
引用
- Ranasinghe KMIU, Senanayake S, Gunasekara S, et al. Surgical Outcome of Pharmaco Refractory Epilepsy in the National Epilepsy Center of Sri Lanka. World Neurosurg. 2024. PMID: 38310948. doi:10.1016/j.wneu.2024.01.153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。